Roche buys Genmark for Covid-19 tests and more
At $1.8bn the acquisition is Roche’s biggest diagnostics deal since it bought Foundation Medicine in 2018.
Astra’s Covid-19 vaccine woes deepen
Denmark’s suspension of AZD1222 following blood clots heaps even more pressure on Astra’s US study.
Roche and Vir add to the conflicting Covid-19 data
A win for Vir’s late-to-the-game antibody and another fail for Roche with Actemra show how developers are still feeling their way in Covid-19.
Adaptive’s Covid-19 T-cell test hits the US
As with antibodies, the next step will be proving that T cells can grant immunity.
Molnupiravir’s big day draws near
Early data whet appetites ahead of the big event for one of the few remaining antiviral hopes in Covid-19.
Roche buys Genmark for Covid-19 tests and more
At $1.8bn the acquisition is Roche’s biggest diagnostics deal since it bought Foundation Medicine in 2018.
Astra’s Covid-19 vaccine woes deepen
Denmark’s suspension of AZD1222 following blood clots heaps even more pressure on Astra’s US study.
Roche and Vir add to the conflicting Covid-19 data
A win for Vir’s late-to-the-game antibody and another fail for Roche with Actemra show how developers are still feeling their way in Covid-19.
Adaptive’s Covid-19 T-cell test hits the US
As with antibodies, the next step will be proving that T cells can grant immunity.
Molnupiravir’s big day draws near
Early data whet appetites ahead of the big event for one of the few remaining antiviral hopes in Covid-19.
